`Filed: November 16, 2015
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`NOVEN PHARMACEUTICALS, INC. and MYLAN I
`PHARMACEUTICALS, INC.,
`Petitioners,
`
`V.
`
`NOVARTIS AG and LTS LOHMANN THERAPIE-SYSTEME
`
`AG,
`Patent Owner.
`
`Case IPR2014—OO549
`
`,
`
`Patent No. 6,316,023 B1
`
`PETITIONER MYLAN’S MANDATORY CHANGE-OF-INFORMATION
`
`NOTICES UNDER 37 C.F.R. § 42.8(a)(3)
`
`
`
`
`
`Case IPR2014—00549
`
`Patent 6,316,023
`
`Pursuant to 37 C.F.R. §.42.8(a)(3), the undersigned on behalf of and acting in a
`
`representative capacity for Co—Petitioner Mylan Pharmaceuticals, Inc. (“Mylan”),
`
`hereby submits the following mandatory change—of-information notices in connection
`
`with the petition for interpartes review of U.S. Patent No. 6,316,023 B1, Case
`
`lPR2014—00549.
`
`A.
`
`Real Party-In-Interest (37 C.F.R. § 42.8(b)(1)) — Unchanged
`
`B.
`
`Related Matters (37 C.F.R. § 42.8(b)(2)) —- Unchanged
`
`C.
`
`Lead and Back—up Counsel (37 C.F.R. § 42.8(b)(3)) _— Revised)
`
`Mylan provides the following updated designation of counsel:
`
`
`
`Michael T. Rosato
`
`Steven W. Parmelee
`
`USPTO Reg. No. 31,990
`WILSON SONSINI GOODRICH &
`
`USPTO Reg. No. 52,182
`WILSON SONSINI GOODRICH &
`
`ROSATI
`
`ROSATI
`
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`
`Tel.: 206-883-2542
`
`Fax: 206-883-2699
`
`Tel.:’206-883-252
`
`Fax: 206-883-2699
`
`Email: sparmelee@wsgr.com
`
`Email: mrosato@wsgr.com
`
`A new power of attorney accompanies this notice.
`
`
`
`Case IPR20l4-00549
`
`Patent 6,316,023
`
`D.
`
`Electronic Service
`
`Petitioner consents to electronic service by email at the email addresses
`
`provided above.
`
`Respectfully submitted,
`
`Date:
`
`/5 I Z0f( J seph M. Reisman, Lead Counsel
`
`Reg. No. 43,878
`
`
`
`Case IPR2014-00549
`
`Patent 6,316,023
`
`CERTIFICATE OF SERVICE
`
`I certify that the foregoing Petitioner’s Mandatory Change—of—Information
`
`Notices under 37 C.F.R. § 42.8(a)(3) and accompanying Petitioner Mylan
`
`Pharmaceuticals, Inc.’s Power of Attorney were served on this 16th day of November,
`
`2015, on Co—Petitioner Noven Pharmaceuticals, Inc., and the Patent Owner at the
`
`correspondence addresses as follows:
`
`CO—PETITIONER NOVEN PHARMACEUTICALS, INC.:
`
`Steven J. Lee
`
`Michael K. Levy
`Christopher Coulson
`KENYON & KENTON LLP
`
`slee@,kenyon.com
`mlevy{cz2kenyon.com
`ccoulson@.kenyon.com
`
`PATENT OWNER:
`
`Raymond R. Mandra, Esquire
`Nicholas N. Kallas, Esquire
`Charlotte Jacobsen, Esquire
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`
`New York, New York 10104-3800
`
`EXelonPatchIPR§a2fchs.com
`
`Date:
`
`/l/M /5 Z0’{
`
`
`
`Respectfully submitted,
`
`oseph M. Reisman, Lead Counsel
`Reg. No. 43,878